LONDON--(BUSINESS WIRE)--
Psychiatric disorders (otherwise termed as mental disorders, or mental illnesses) stand for a broad range of problems, including anxiety disorders (post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder,andphobias); bipolar disorder (also known as maniac-depressive illness); depression; mood disorders; personality disorders; psychotic disorders (includingschizophrenia). The causes are varied, including genes and family history; life experiences, like stress or a history of abuse; biological factors; a traumatic brain injury; a mother's exposure to viruses or toxic chemicals during her pregnancy; and, to a lesser extent, the use of illegal drugs or a serious medical condition like cancer.
The treatment depends upon the psychiatric disorders type, its severity as well as what works best for a particular patient. Most commonly, a combination of treatments is used, encompassing psychiatricmedications; psychotherapy (also named talk therapy or psychological counseling); brain-stimulation treatments; hospitalisation and residential treatment programs; and others.
Discounted study Psychiatric Disorders - Pipeline Review, H1 2013 elaborated by Global Markets Direct provides an up-close look atthe global therapeutic scenario for psychiatric disorders.
The report gives an overview of the psychiatric disorders products under development by companies and different research organisations; examines the products being in various phases of development from discovery till registration; features pipeline projects on the basis of monotherapy and combined therapeutics; analyses the psychiatric disorders pipeline in terms of route of administration and molecule type; uncovers the discontinued projects, besides looking into the factors that drove them from pipeline. Furthermore, the top companies involved in the therapeutic development for psychiatric disorders are identified, as well as the latest news and deals relating to the products are also addressed in the research.
Report Details:
Title: Psychiatric Disorders - Pipeline Review, H1 2013
Published: April, 2013
Pages: 409
Price: US$ 2,125.00